Condensed Consolidated Statements of Shareholders’ Equity (Unaudited) - USD ($) shares in Millions, $ in Millions		Total	Ordinary Shares and Additional Paid-in Capital	Accumulated Deficit	Accumulated  Other Comprehensive Loss, Net of Tax	Non- redeemable Non- controlling Interests
Beginning balance (in shares) at Dec. 31, 2023			198.6
Beginning balance at Dec. 31, 2023		$ (742)	$ 6,946	$ (3,399)	$ (4,373)	$ 84
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income		1,093		1,071		22
Shares issued - employee stock compensation plans (in shares)			0.8
Shares issued - employee stock compensation plans		(104)	$ (104)
Shares repurchased (in shares)			(0.8)
Shares repurchased		(250)		(250)
Share-based compensation expense		130	$ 130
Dividends to shareholders		(122)		(122)
Net change in fair value of financial instruments		75			75
Net foreign currency translation adjustments		(132)			(132)
Net postretirement benefit obligation		26			26
Purchases of subsidiary shares from nonredeemable noncontrolling interests		(1)	$ (1)
Dividends paid to nonredeemable noncontrolling interests on subsidiary common stock		(1)				(1)
Ending balance (in shares) at Mar. 31, 2024			198.6
Ending balance at Mar. 31, 2024		(28)	$ 6,971	(2,700)	(4,404)	105
Beginning balance (in shares) at Dec. 31, 2023			198.6
Beginning balance at Dec. 31, 2023		(742)	$ 6,946	(3,399)	(4,373)	84
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net change in fair value of financial instruments		76
Net foreign currency translation adjustments		(220)
Net postretirement benefit obligation		39
Ending balance (in shares) at Jun. 30, 2024			217.2
Ending balance at Jun. 30, 2024		6,028	$ 12,912	(2,574)	(4,478)	168
Beginning balance (in shares) at Mar. 31, 2024			198.6
Beginning balance at Mar. 31, 2024		(28)	$ 6,971	(2,700)	(4,404)	105
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	[1]	536		524		12
Shares issued - NFP Transaction (in shares)			19.0
Shares issued - NFP Transaction		5,882	$ 5,882
Shares issued - employee stock compensation plans (in shares)			0.4
Shares issued - employee stock compensation plans		(45)	$ (45)
Shares repurchased (in shares)			(0.8)
Shares repurchased		(250)		(250)
Share-based compensation expense		117	$ 117
Dividends to shareholders		(148)		(148)
Net change in fair value of financial instruments		1			1
Net foreign currency translation adjustments		(88)			(88)
Net postretirement benefit obligation		13			13
Purchases of subsidiary shares from nonredeemable noncontrolling interests		86				86
Dividends paid to nonredeemable noncontrolling interests on subsidiary common stock		(35)				(35)
Remeasurement of redemption value of redeemable noncontrolling interest		(13)	$ (13)
Ending balance (in shares) at Jun. 30, 2024			217.2
Ending balance at Jun. 30, 2024		$ 6,028	$ 12,912	(2,574)	(4,478)	168
Beginning balance (in shares) at Dec. 31, 2024		216.0	216.0
Beginning balance at Dec. 31, 2024		$ 6,305	$ 13,175	(2,309)	(4,745)	184
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	[2]	986		965		21
Shares issued - employee stock compensation plans (in shares)			0.7
Shares issued - employee stock compensation plans		(111)	$ (111)
Shares repurchased (in shares)			(0.6)
Shares repurchased		(250)		(250)
Share-based compensation expense		147	$ 147
Dividends to shareholders		(146)		(146)
Net change in fair value of financial instruments		3			3
Net foreign currency translation adjustments		239			239
Net postretirement benefit obligation		47			47
Dividends paid to nonredeemable noncontrolling interests on subsidiary common stock		(14)				(14)
Remeasurement of redemption value of redeemable noncontrolling interest		(11)	$ (11)
Ending balance (in shares) at Mar. 31, 2025			216.1
Ending balance at Mar. 31, 2025		$ 7,195	$ 13,200	(1,740)	(4,456)	191
Beginning balance (in shares) at Dec. 31, 2024		216.0	216.0
Beginning balance at Dec. 31, 2024		$ 6,305	$ 13,175	(2,309)	(4,745)	184
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net change in fair value of financial instruments		13
Net foreign currency translation adjustments		843
Net postretirement benefit obligation		$ 46
Ending balance (in shares) at Jun. 30, 2025		215.7	215.7
Ending balance at Jun. 30, 2025		$ 8,008	$ 13,260	(1,574)	(3,843)	165
Beginning balance (in shares) at Mar. 31, 2025			216.1
Beginning balance at Mar. 31, 2025		7,195	$ 13,200	(1,740)	(4,456)	191
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	[3]	593		579		14
Shares issued - employee stock compensation plans (in shares)			0.3
Shares issued - employee stock compensation plans		(50)	$ (49)	(1)
Shares repurchased (in shares)			(0.7)
Shares repurchased		(250)		(250)
Share-based compensation expense		119	$ 119
Dividends to shareholders		(162)		(162)
Net change in fair value of financial instruments		10			10
Net foreign currency translation adjustments		604			604	0
Net postretirement benefit obligation		(1)			(1)
Purchases of subsidiary shares from nonredeemable noncontrolling interests		(9)	(9)
Dividends paid to nonredeemable noncontrolling interests on subsidiary common stock		(40)				(40)
Remeasurement of redemption value of redeemable noncontrolling interest		$ (1)	$ (1)
Ending balance (in shares) at Jun. 30, 2025		215.7	215.7
Ending balance at Jun. 30, 2025		$ 8,008	$ 13,260	$ (1,574)	$ (3,843)	$ 165

[1] The Company’s Net income totaled $538 million for the quarter ended June 30, 2024, which included $2 million of Net income related to redeemable noncontrolling interests.

[2] The Company’s Net income totaled $982 million for the quarter ended March 31, 2025, which included $4 million of Net loss related to redeemable noncontrolling interests.

[3] The Company’s Net income totaled $594 million for the quarter ended June 30, 2025, which included $1 million of Net gain related to redeemable noncontrolling interests.